...
首页> 外文期刊>Future medicinal chemistry >Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase
【24h】

Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase

机译:对人单胺氧化酶的原子缀合1,2,3-三唑的同种型选择性

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: There is little information available on the monoamine oxidase isoform selectivity of N-alkyl harmine analogs, which exhibit a myriad of activities including MAO-A, DYRK1A and cytotoxicity to several select cancer cell lines. Results: Compounds 3e and 4c exhibited an IC50 of 0.83 +/- 0.03 and 0.43 +/- 0.002M against MAO-A and an IC50 of 0.26 +/- 0.04 and 0.36 +/- 0.001M against MAO-B, respectively. Molecular docking studies revealed - interactions between the synthesized molecules and aromatic amino acid residues. Conclusion & future perspective: The current study delineates the structural requirements for MAO-A selectivity and such information may be helpful in designing selective analogs for kinase, DYRK1A and harmine-based cytotoxics without apparent MAO enzyme inhibition.
机译:目的:在单胺氧化酶同种型的N-烷基氧化酶同种型选择性的信息很少,其表现出包括MAO-A,Dyrk1a和细胞毒性的多种活性,以几种选择癌细胞系。 结果:化合物3E和4C分别显示出0.83 +/- 0.03和0.43 +/- 0.002M的IC50,抵抗MAO-A和0.26 +/- 0.04和0.36 +/- 0.001M的IC50,对抗MAO-B。 分子对接研究显示 - 合成分子与芳族氨基酸残基之间的相互作用。 结论和未来的视角:目前的研究描绘了毛泽东的结构要求,这种信息可能有助于设计Kinase,Dyrk1a和基于气氨酸的细胞毒性的选择性类似物,而无明显毛酶抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号